Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasi

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03897088
Recruitment Status : Active, not recruiting
First Posted : April 1, 2019
Last Update Posted : February 11, 2021
Sponsor:
Information provided by (Responsible Party):
Sun Pharma Global FZE

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : January 13, 2021
Estimated Study Completion Date : February 2022